Sample quality and its influence on tumor and germline variant analysis - Molecular HealthMolecular Health

Have a question?

Phone +1-978-491-8393

Whitepaper: Sample quality and its influence on tumor and germline variant analysis

The quality of genomic tumor analyses depends on the tumor biopsy, on sample storage and shipment conditions,
and on the NGS lab test used.
This white paper shows the influence of these parameters on the final analysis result, shown as variant allele frequency (VAF).
This frequency is a measure of the prevalence of mutated tumor cells, and essential for selecting the best therapy.

To download this whitepaper please submit the form below:

I agree that my name, email address, and any other information I provide, can be transferred to Molecular Health GmbH and processed there for the purpose of answering my request. I have read the privacy policy and hereby agree that my personal data may be processed as described. I can revoke this agreement at any time.